New test could prevent fluid overload in sick kids

NCT ID NCT07522580

Recruiting now Diagnosis Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new, noninvasive method to quickly determine if critically ill children need intravenous fluids. The method uses gentle abdominal pressure and a device that measures blood flow. If accurate, it could help doctors avoid giving unnecessary fluids, which can be harmful. The study involves 42 children in intensive care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give doctors a fast, safe way to decide which children need IV fluids, reducing the risk of fluid overload.
What could go wrong: This is a small, early diagnostic study with only 42 children, so results may not apply to all patients. The test may not be accurate enough to replace current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRCULATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest Shock

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRCULATORY FAILURE FLUID THERAPY SHOCK STATE

Contacts and locations

Locations

Hôpital Arnaud de Villeneuve - CHU de Montpellier
NOT_YET_RECRUITING

Montpellier, France, 34295, France
Hôpital Cardiologique Haut Lévêque - CHU de Bordeaux
RECRUITING

Pessac, France, 33600, France
Hôpital Marie Lannelongue
NOT_YET_RECRUITING

Le Plessis-Robinson, France, 92350, France
Hôpital mère-enfant - CHU de Nantes
NOT_YET_RECRUITING

Nantes, France, 44093, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.